A threat has been made to impose a 250% tariff on pharmaceuticals. The potential impact of such a tariff is uncertain, with some reports suggesting key exemptions could limit its effects, while others note that certain countries may be exempt, such as the UK, which has had its pharma tariffs removed. It is also unclear if the tariff will be implemented, as there are reports of a deal that may have led to a backing down from the threatened tariff, at least with regard to the EU.